Nutritional support and cardioprotection with L-carnitine: prescription appropriateness and safety concerns in

Leobardo Manuel Gómez-Oliván1, Analleli Valdés-Alanis, Lucila I Castro-Pastrana

  • 1Laboratorio de Toxicología, Departamento de Farmacia, Facultad de Química, Universidad Autónoma del Estado de México, Paseo Tollocan esquina Paseo Colón. Col. Universidad. Toluca, Estado de México.

Insights

L-carnitine prescriptions in a neonatal intensive care unit (NICU) were often inappropriate, with incorrect dosing in over 60%. Adverse drug reactions, primarily gastrointestinal issues, were common, highlighting the need for a rational use policy.

Area of Science:

  • Neonatal Medicine
  • Clinical Pharmacy
  • Pediatric Pharmacology

Background:

  • Medication errors are a significant concern in neonatal care.
  • L-carnitine is frequently used in Mexican NICUs for nutritional support and treating neonatal asphyxia-related cardiomyopathy.

Purpose of the Study:

  • To evaluate the appropriateness of L-carnitine prescriptions in a Mexican NICU.
  • To identify adverse drug reactions (ADRs) associated with L-carnitine therapy.

Main Methods:

  • A longitudinal-retrospective study design was employed.
  • Assessed L-carnitine prescriptions over a 12-month period.
  • Collected and characterized ADR reports possibly related to L-carnitine.

Main Results:

  • Only 18% of L-carnitine administrations were deemed appropriate.
  • 60.7% of prescriptions had inappropriate doses outside recommended ranges.
  • The overall ADR rate was 18.03%, with gastrointestinal issues (cramps, vomiting) being most frequent.

Conclusions:

  • L-carnitine use in this NICU was largely inappropriate, particularly regarding dosing.
  • Gastrointestinal adverse events were common with L-carnitine therapy.
  • A rational use policy for L-carnitine is recommended for this NICU.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...